Early prosthetic joint infections treated with debridement and implant retention: 38 primary hip arthroplasties prospectively recorded and followed for median 4 years by Westberg, Marianne et al.
Acta Orthopaedica 2012; 83 (3): 227–232  227
Early prosthetic joint infections treated with debridement and 
implant retention
38 primary hip arthroplasties prospectively recorded and followed for median 
4 years
Marianne Westberg1, Bjarne Grøgaard1, and Finnur Snorrason2
1Department of Orthopaedics, Oslo University Hospital, Oslo; 2Department of Orthopaedics, Drammen Hospital, Drammen, Norway
Correspondence: marianne.westberg@oslo-universitetssykehus.no 
Submitted 11-07-15. Accepted 11-12-27
Open Access - This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, 
distribution, and reproduction in any medium, provided the source is credited.
DOI 10.3109/17453674.2012.678801
Background and purpose   Debridement and retention of the pros-
thesis is often attempted to treat early prosthetic joint infection 
(PJI). However, previous studies have found inconsistent results, 
with success rates ranging from 21% to 100%, and little has been 
written in the literature about hip function. We have therefore 
analyzed the clinical and functional outcome of early PJIs treated 
with this procedure.
Patients and methods   38 patients with early PJI after primary 
hip arthroplasty who were treated with debridement and reten-
tion of the implant between 1998 and 2005 were studied prospec-
tively, with a median follow-up time of 4 (0.8–10) years. Early 
infection was defined as that which occurred within 4 weeks of 
index arthroplasty. The primary outcome measure was infection 
control. Functional outcome was assessed with the Harris hip 
score.
Results   27 of 38 patients were successfully treated, with no 
signs of infection or continued antibiotic treatment at the latest 
follow-up. Median Harris hip score was 86 (47–100) points. In 9 
of the 11 patients for whom treatment failed, infection was suc-
cessfully treated with 1-stage or 2-stage reimplantation or resec-
tion. Intraoperative cultures were positive in 36 hips, and the 
most frequently isolated organisms were Staphylococcus aureus 
and coagulase-negative staphylococci (CoNS). 15 infections were 
polymicrobial, and only 8 of them were successfully treated with 
debridement and retention of the implant. 
Interpretation   Our data suggest that debridement and reten-
tion of the prosthesis is a reasonable treatment option in early 
PJI after primary hip arthroplasty, with satisfactory functional 
results. 

Prosthetic joint infection (PJI) occurs with an incidence of 
around 1% after primary hip surgery (NIH consensus confer-
ence 1995, Gaine et al. 2000, Phillips et al. 2006). The number 
of patients requiring a joint replacement is steadily increasing, 
and the absolute number of PJIs will be rising (NIH consensus 
conference 1995). Recent publications even suggest that the 
incidence of infection is increasing (Kurtz et al. 2008, Dale 
et al. 2009). 
In early PJI, debridement with retention of the implant is an 
attractive treatment option. This procedure reduces morbidity, 
and also length of hospital stay and costs, compared to 1-stage 
or 2-stage revision arthroplasty (Fisman et al. 2001). The 
reported success rates of this procedure range from 21% to 
100% (Drancourt et al. 1993, Tsukayama et al. 1996, Brandt 
et al. 1997, Crockarell et al. 1998, Zimmerli et al. 1998, Bar-
beran et al. 2006, Choong et al. 2007, Van Kleunen et al. 
2010). Different definitions of acute postoperative infection, 
with length varying from 4 weeks to 3 months, combined with 
heterogenous patient series, make comparison of these studies 
difficult.
Here we evaluated the clinical outcome of early PJI treated 
with debridement and retention of the implant in an 8-year 
prospective cohort.
 
Patients and methods
All primary total hip replacements (THRs) at our center were 
prospectively recorded as part of a quality registration between 
January 1998 and December 2005. We studied the early PJIs 
in this THR cohort. PJI was classified as being early when 
symptoms presented less than 4 weeks after arthroplasty, 
according to Segawa and Tsukayama (Tsukayama et al. 1996). 
Infection was diagnosed clinically and was based on the CDC 
definition of deep incisional surgical site infection (Mangram 
et al. 1999). 8 biopsies and joint aspirates were taken peri-228  Acta Orthopaedica 2012; 83 (3): 227–232
operatively, and a minimum of 2 tissue specimens had to be 
positive before we regarded the organism isolated as being the 
infecting organism.
40 consecutive cases of early PJI were identified, 38 of 
which were treated with debridement and retention of compo-
nents and were included for further analysis (Table 1). The 2 
patients who were not included were treated with suppressive 
antibiotic therapy. 
When an infection was diagnosed, the microbiological 
agent(s), the type of treatment, the duration of antimicrobial 
treatment, and the number of days in hospital were registered. 
Total stay in hospital was defined as the cumulative duration 
of all admissions required to treat the infection.The final clini-
cal visit was conducted in 2008.
Recruitment to the study was contingent upon obtaining 
informed consent from the patient. The study was approved 
by the Regional Committee for Ethics in Medical Research 
(1.2007.364) and the Norwegian Data Inspectorate. 
Treatment 
We aimed for early surgical debridement, preferably within 
4 weeks of the index operation. The median time until initial 
debridement was 20 (11–63) days, and 33 of the patients were 
operated within 4 weeks. 29 patients underwent 1 soft tissue 
debridement and 9 patients underwent a second debridement 
median 14 (9–30) days after the first revision. None of the 
prostheses were found to be loose and there were no discharg-
ing sinus tracts.
The standard index approach was transgluteal. At soft tissue 
revision, the surgical strategy was to excise the wound mar-
gins and to remove all debris and necrotic soft tissue, followed 
by pulsatile lavage with several liters of saline. Any modular 
component was changed. None of the patients had received 
antibiotics prior to culture, and antibiotics were withheld until 
the biopsies had been obtained. An empirical intravenous 
antimicrobial regimen, vancomycin in combination with a 
b-lactam, was started perioperatively and maintained until the 
definitive microbiological results were known. Organism-spe-
cific antibiotics were then given. The duration of antimicrobial 
therapy was chosen arbitrarily by the treating surgeons, based 
on clinical signs and laboratory tests.
Evaluation of outcome 
The primary outcome measure was the presence or absence of 
PJI at the latest clinical follow-up. A second soft tissue revi-
sion was not regarded as a failure. At the latest follow-up visit, 
the patients were clinically assessed, and blood tests were 
obtained, including erythrocyte sedimentation rate (ESR) and 
C-reactive protein (CRP). Postoperative and follow-up radio-
graphs were evaluated for signs of loosening (radiolucent 
lines more than 2 mm wide, migration, and osteolysis) and 
subperiosteal bone growth. Functional outcome was assessed 
by the use of the Harris hip score with a maximum score of 
100 points (representing no disability).
A successful outcome was defined as lack of clinical signs 
and symptoms of infection, a CRP level of < 10 mg/L, ESR 
the same as before the index operation, and absence of radio-
logical signs of loosening. Failure was defined as relapse of 
infection, with isolation of the same or another pathogen.
Statistics
Fisher’s exact test was used to compare categorical variables. 
A p-value of < 0.05 was considered significant. 
Results
Treatment outcome (Figure) 
After a median follow-up time of 4 (0.8–10) years, treatment 
with soft tissue debridement and retention of the prosthesis 
was successful in 27 of the 38 hips. These patients had no clin-
ical signs of infection and no longer had antimicrobial therapy. 
In the patients treated within 3 weeks of the index operation, 
18 of 24 healed, and 9 of the 14 infections that were treated 
after 3 weeks also healed (p = 0.7). Thus, treatment failed in 
11 of the 38 patients. 
In the patients in whom treatment failed, soft tissue debride-
ment was performed median 5 (4–7) weeks postoperatively. 
The failures occurred median 7 (5–133) weeks after the index 
operation. 6 of the failures were managed successfully with 
1- or 2-stage revision arthroplasty. In 3 patients, the infection 
was controlled by removal of the prosthesis without reimplan-
tation. In 1 patient, 2-stage exchange failed and the infection 
was treated with chronic antibiotic suppression. 1 patient had 
the prosthesis removed, but the infection was not controlled 
despite several attempts at additional soft tissue revisions. 
This patient was immunocompromised because of a kidney 
transplant. 
Functional outcome 
26 of the 38 patients were completely rated with Harris hip 
score at the latest follow-up. Overall, median Harris hip score 
was 79 (25–100) points. In the group successfully treated 
Table 1. Patient demographics in 38 patients treated for early PJI
Variable Value
Age in years, median (range)   75 (32–89)
  Male/female   15/23
  BMI, median (range)   29 (19–49)
  ASA score, median (range)     2 (1–3)
Indication for arthroplasty
  OA/AVN/FS   33/3/2
Procedure
  Cemented/uncemented/reverse hybrid THA   36/1/1
BMI: body mass index; 
ASA: American Society of Anesthesiologists; 
OA: osteoarthritis; AVN: avascular necrosis; FS: fracture sequelae.Acta Orthopaedica 2012; 83 (3): 227–232  229
with retained prosthesis and no signs of infection, median 
Harris hip score was 86 (47–100) points. In the patients who 
were reoperated with removal of the prosthesis, with or with-
out reimplantation, median Harris hip score was 66 (25–90) 
points. The number of patients rated in these 2 groups were 20 
and 6, respectively.
Microbiology
Intraoperative cultures were positive in 36 of 38 patients. 
The most frequently isolated organism was Staphylococcus 
aureus, which was the sole causative pathogen in 10 hips. 
Altogether, it was isolated from 21 patients. None of the 
strains were methicillin-resistant. Coagulase-negative staphy-
lococci (CoNS) were the sole causative pathogen in 7 hips and 
there were 18 isolates in total. 4 were methicillin-resistant. 15 
of the infections were polymicrobial (Tables 2 and 3). 
All 10 monomicrobial S. aureus infections were successfully 
treated with debridement and retention of the prosthesis. Only 
8 of the 15 polymicrobial infections were treated successfully, 
as compared to 19 of the other 23 PJIs (p = 0.07). 4 of 7 mono-
microbial CoNS infections, 1 of which was methicillin-resis-
tant, were debrided with successful outcome (Table 2).
Antimicrobial therapy
When definitive microbiological results were known, b-lac-
tam drugs (cloxacillin, dicloxacillin, and penicillin)—alone or 
in combination with clindamycin—were used in 30 of the 38 
hips. Subsequently, 8 hips were treated with linezolid and 3 
hips were treated with a rifampicin combination. The median 
total duration of antimicrobial therapy, including treatment 
when additional revision procedures were performed, was 7 
(3–39) weeks. The median duration of antimicrobial therapy 
for the 27 patients who were treated successfully was 7 (3–27) 
weeks. The median total stay in hospital was 6 (2–14) weeks. 
Complications and reoperations 
2 patients developed nephrotoxicity, which was vancomy-
cin-induced in 1 patient and b-lactam-induced in one with a 
kidney transplant. 10 patients died during the follow-up. All 
but 1 death had causes unrelated to the infection. 8 patients 
had dislocation of the hip postoperatively.
Flow chart of 38 hips with early PJI treated with debridement and implant retention
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Table 2. Microbiological findings and treatment outcome in 38 
patients treated for early PJI
            
  A  B  C  D E
Coagulase-negative staphylococci  7  4  3
Staphylococcus aureus  10 10
Streptococci  2  1 1
Enterococci  1 1
Propionibacterium acnes  1 1
Culture-negative infection  2  2
Polymicrobial infection  15  8  5  2
     
A Microorganism 
B  No. of episodes
C PJIs cured with debridement and retention of prosthesis 
D PJIs cured after 1- or 2-stage exchange or resection arthroplasty  
E  Chronic infection230  Acta Orthopaedica 2012; 83 (3): 227–232
Discussion
Our main finding was favorable outcome after debridement 
and retention of the prosthesis in early PJIs after primary THR. 
Patients who were treated successfully had a satisfactory func-
tional outcome with a median Harris hip score of 86 points at 
the latest follow-up. Moreover, we found a high rate of poly-
microbial infections with a tendency of poorer outcome. 
One of the patients was immunocompromised because of a 
kidney transplant. This patient developed a severe polymicro-
bial PJI, failed all treatment efforts, and eventually died of the 
infection. This patient was quite different from the otherwise 
homogenous patient group, with an expected poorer outcome. 
If we exclude this patient, the treatment would have been suc-
cessful in 27 of 37 patients. It would not have affected our 
general findings, though. 
The recommended length of time between arthroplasty, or 
signs of infection, and soft tissue debridement is an impor-
tant and much debated question. Long duration of symptoms 
has been found to increase the risk of treatment failure, and 
hence soft tissue debridement within a week after debut of 
symptoms is recommended (Brandt et al. 1997, Tattevin et al. 
1999, Marculescu et al. 2006). Others recommend this treat-
ment within 3 weeks after arthroplasty (Zimmerli et al. 2004). 
We do not have data on duration of symptoms, but we did not 
find a time-dependent association between treatment failure 
and time from arthroplasty. This could be because all the PJIs 
were treated within a relatively short time after arthroplasty, or 
it could be due to the low number of patients. 
The most common microorganisms cultured in PJI are 
Staphylococcus aureus and CoNS, which account for more 
than half of the cultures (Tsukayama et al. 1996, Pandey et 
al. 2000, Widmer 2001). CoNS and S. aureus were the most 
frequently isolated organisms in the present study also. CoNS 
were present in 10 of 15 polymicrobial infections, and in 
all 18 CoNS isolates were detected. This demonstrates how 
important CoNS are in acute PJI, and not only (as traditionally 
considered) in late infections. 
The number of methicillin-resistant CoNS (MRSE) infec-
tions in our study was low, which contrasts with other PJI 
reports on increasing numbers of MRSE infections (Stefáns-
dóttir et al. 2009). We have no clear explanation for the low 
incidence of MRSE, but it may have been due to the small 
material. In addition, our study involved only acute infec-
tions, and methicillin resistance is increasing with the number 
of reoperations and duration of infection. The phenotyping 
methods used to test CoNS for methicillin resistance in the 
period 1998–2005 were also less sensitive than the molecular 
methods used today.
S. aureus has been associated with higher failure rates 
(Brandt et al. 1997), but this correlation has not been shown 
in other series (Zimmerli et al. 1998, Barberan et al. 2006). 
We did not find this tendency in our material. None of the S. 
aureus strains in our series were methicillin-resistent.
We found that 15 of 38 infections were polymicrobial. 
This is somewhat higher than previously reported in the lit-
erature, where polymicrobial PJI has accounted for 5–22% 
of all PJI (Tsukayama et al. 1996, Gardner et al. 2011, Van 
Kleunen et al. 2010). In 2 recent studies, polymicrobial PJIs 
were more frequent in the early infections (Moran et al. 2007, 
Marculescu and Cantey 2008). The fact that our series only 
involved early PJIs may explain the high number of polymi-
crobial infections. Polymicrobial PJI has been associated with 
poor outcome (Jackson and Schmalzried 2000, Marculescu 
and Cantey 2008). We also found lower success rates with 
the polymicrobial infections than with other infections, but 
this was not statistically significant (p = 0.07). This supports 
previous reports about polymicrobial PJIs being a prognostic 
Table 3. Details of 15 polymicrobial PJIs treated with debridement and retention of the prosthesis
  Infecting organisms  Outcome after debridement  Additional surgical  Final
    and implant retention  procedures  outcome
  1.  S. aureus + E. coli  Success
  2.  S. aureus + Streptococcus  Failure  2-stage exchange arthroplasty  Success
  3.  CoNS + Enterococcus + Corynebacterium  Failure  2-stage exchange arthroplasty  Failure
  4.  S. aureus + MRSE + Enterococcus  Success
  5.  CoNS + Streptococcus  Success
  6.  CoNS + MRSE  Failure  2-stage exchange arthroplasty  Success
  7.  S. aureus + CoNS  Failure  2-stage exchange arthroplasty  Success
  8.  S. aureus + CoNS  Failure  1-stage exchange arthroplasty  Success
  9.  S. aureus + CoNS  Failure  Resection arthroplasty  Success
 10.  CoNS + Enterococcus  Success
 11.  S. aureus + Enterococcus  Success
 12.  S. aureus + E. coli  Success
 13.  S. aureus + Streptococcus  Failure  Resection arthroplasty  Failure
 14.  S. aureus + CoNS + Enterococcus  Success
 15.  S. aureus + MRSE   Success 
CoNS: coagulase-negative staphylococci; 
MRSE: methicillin-resistant staphylococcus epidermidis.Acta Orthopaedica 2012; 83 (3): 227–232  231
factor for failure. The polymicrobial infections in our series 
also had a higher frequency of enterococci and Gram-negative 
organisms than in the monomicrobial PJIs. These organisms 
are known to be difficult to treat, and may partly explain the 
inferior treatment results in the polymicrobial PJIs.
The optimal length of antimicrobial treatment of PJI is not 
clear. Current recommendations are 3 months in patients with 
early PJI of the hip (Zimmerli et al. 1998). It has recently been 
suggested that treatment may be restricted to 6 weeks (Bernard 
et al. 2010). The antimicrobial therapy in our material was not 
standardized, with great time variation, but the median time of 
treatment was considerably shorter than the recommended 3 
months. This may support the suggestion of shorter duration 
of antimicrobial therapy in early PJI.
A previous report has suggested that attempting salvage of 
the prosthesis with soft tissue debridement may reduce the 
chance of successful reimplantation later on (Gardner et al. 
2011). In a review of the literature, Jackson and Schmalzried 
(2000) reported a success rate of 83% in 1,299 PJIs treated with 
1-stage exchange. Historically, 2-stage exchange arthroplasty 
has been the treatment of choice in PJI, with success rates of 
around 90% (Tsukayama et al. 1996, Hsieh et al. 2004, San-
chez-Sotelo et al. 2009). Our findings are in accordance with 
these reports: an initial attempt at debridement does not lead 
to inferior results at later revision arthroplasty.
Data on functional results following debridement and reten-
tion of prosthesis are often lacking in the literature. Hence, the 
expected level of Harris hip score is not clear. Tsukayama et 
al. (1996) evaluated 28 patients treated with soft tissue revi-
sion for early PJI, and reported 70 points for Harris hip score 
on average. The functional results after 1-stage and 2-stage 
revision surgery have been reported, with Harris hip score 
between 69 and 87 (Tsukayama et al. 1996, Hsieh et al. 2004, 
Cabrita et al. 2007). In our series, the average Harris hip score 
in patients who were managed successfully with soft tissue 
revision was 86. This is not as good as anticipated after pri-
mary THR, but appears to be similar to other reported results 
after PJIs. 
The present study had several limitations. First, the debride-
ment procedure was not done using a standardized protocol, 
and individual surgeons may have performed the procedure 
differently. However, only 5 different surgeons were involved 
in the treatment of the infected THRs. Secondly, there were 
no established guidelines for the type and duration of the 
antimicrobial treatment; each regimen was chosen individu-
ally by the treating surgeon. The treatment changed during 
the study period. In the second half of the period, linezolid- 
and rifampin-containing regimens were used in some of the 
patients. Variations in choice of treatment may have influ-
enced the treatment results. Finally, the study population was 
relatively small. It is therefore difficult to determine poten-
tial risk factors associated with treatment failure. The study 
was, however, strengthened by its prospective registration and 
homogenous study population.
In summary, our findings support the use of debridement 
and retention of the prosthesis in early PJI of the hip. The 
functional outcome after this surgical strategy appears to be 
acceptable. CoNS and polymicrobial infections are frequently 
the cause of early PJI, which emphasizes the importance of 
broad-spectrum antimicrobial treatment initially. It is neces-
sary to have a high index of suspicion of PJI, and to respond 
without delay in order to optimize the treatment results with 
this surgical modality.
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